Janet Dillione - Dec 2, 2025 Form 4 Insider Report for CorMedix Inc. (CRMD)

Role
Director
Signature
/s/ Janet Dillione
Stock symbol
CRMD
Transactions as of
Dec 2, 2025
Transactions value $
-$281,768
Form type
4
Date filed
12/4/2025, 09:30 PM
Previous filing
Nov 26, 2025

Reporting Owners (1)

Name Relationship Address Signature Signature date CIK
Dillione Janet Director C/O CORMEDIX INC.,, 300 CONNELL DRIVE, SUITE 4200, BERKELEY HEIGHTS /s/ Janet Dillione 2025-12-04 0001489798

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
transaction CRMD Common Stock Options Exercise $49.2K +12.2K +25.19% $4.03 60.7K Dec 2, 2025 Direct
transaction CRMD Common Stock Options Exercise $67K +15.1K +24.92% $4.43 75.8K Dec 2, 2025 Direct
transaction CRMD Common Stock Options Exercise $68.6K +19.3K +25.49% $3.55 95.1K Dec 2, 2025 Direct
transaction CRMD Common Stock Sale -$467K -46.7K -49.05% $10.00 48.5K Dec 2, 2025 Direct

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Underlying Class Amount Exercise Price Ownership Footnotes
transaction CRMD Stock Option (Right to Buy Common Stock) Options Exercise $0 -12.2K -100% $0.00 0 Dec 2, 2025 Common Stock 12.2K $4.03 Direct F1
transaction CRMD Stock Option (Right to Buy Common Stock) Options Exercise $0 -15.1K -100% $0.00 0 Dec 2, 2025 Common Stock 15.1K $4.43 Direct F2
transaction CRMD Stock Option (Right to Buy Common Stock) Options Exercise $0 -19.3K -79.44% $0.00 5K Dec 2, 2025 Common Stock 19.3K $3.55 Direct F3
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Buy Plan / Sale Plan: These are also open market purchases/sales of shares, but in this case the transaction is part of a trading plan. Rule 10b5-1 allows insiders to setup a trading plan to buy/sell stocks over a certain period of time. Since the purchases/sales are predetermined, this protects the insiders from violating insider trading law.

Transaction was made pursuant to a contract, instruction or written plan for the purchase or sale of equity securities of the issuer that is intended to satisfy the affirmative defense conditions of Rule 10b5-1(c).

Explanation of Responses:

Id Content
F1 These options were granted on 02/22/2022. These options are fully vested.
F2 These options were granted on 01/14/2023. These options are fully vested.
F3 These options were granted on 03/05/2024. These options are fully vested.